Health Care·Health Care Services·$7.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.11 | N/A | -10.57% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.11 | N/A | -10.57% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed a cautious optimism about future growth. They highlighted the importance of expanding their customer base as a key focus.
We are focused on long-term growth despite short-term challenges.
Our customer base continues to expand, which is a positive sign.
HIMS & HERS reported an EPS of $0.11, which was below expectations, but the stock still rose by 4.12%. This increase may reflect investor confidence in the company's long-term growth strategy, despite the EPS miss. The management's focus on expanding their customer base suggests potential for future revenue growth.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BALCHEM CORP
Feb 21, 2025